The search strategy incorporated terms related to GLP-1 receptor agonists (e.g., GLP-1, Semaglutide, Liraglutide, Exenatide) in combination with alcohol use concepts (e.g., alcohol, alcohol use disorder, binge drinking, ethanol)
A systematic review and meta-analysis [47] further quantified the impact of LMP mutations on bariatric surgery outcomes
However, expectations need to be grounded in reality
GLP-1 agonists include Liraglutide (Victoza), subcutaneous Semaglutide (Ozempic), Tirzepatide (Wegovy) and Dulaglutide (Trulicity)
Some people may also receive GLP-1 medications to manage health conditions like type 2 diabetes
Its unpredictable whether microdosing would have a similar effect since some patients feel almost nothing on the lower doses, McGowan notes